indications for semaglutide fda approved FDA approves Ozempic® (semaglutide) as the only GLP-1 RA to Semaglutide vs Tirzepatide: Dosing, Results,

Commonly reported side effects include: Nausea, vomiting, and diarrhoea particularly during dose escalation Constipation and abdominal discomfort Decreased appetite and early satiety Injection site reactions (mild and transient) Fatigue, especially in the initial weeks of treatment These gastrointestinal effects are consistent with the GLP-1 mechanism and are generally dose-dependent and transient

use a fresh needle each week and rotate injection sites

DAP, DJE, JBK and VMJ are stockholders of Pfizer Inc

I had occasion to chat with the clinic twice, and the folks were polite, respectful, and answered all my questions satisfactorily

For more plain-English comparisons, visit the Xeteor OTC & Diabetes Guides

And this is where protein comes in